Literature DB >> 25681562

Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development.

C M Bonaccorso1, M Spatuzza2, B Di Marco3, A Gloria1, G Barrancotto1, A Cupo4, S A Musumeci1, S D'Antoni2, B Bardoni5, M V Catania6.   

Abstract

Fragile X syndrome is caused by the lack of expression of fragile X mental retardation protein (FMRP), an RNA-binding protein involved in mRNA transport and translation. FMRP is a component of mRNA ribonucleoprotein complexes and it can interact with a range of proteins either directly or indirectly, as demonstrated by two-hybrid selection and co-immunoprecipitation, respectively. Most of FMRP-interacting proteins are RNA-binding proteins such as FXR1P, FXR2P and 82-FIP. Interestingly, FMRP can also interact directly with the cytoplasmic proteins CYFIP1 and CYFIP2, which do not bind RNA and link FMRP to the RhoGTPase pathway. The interaction with these different proteins may modulate the functions of FMRP by influencing its affinity to RNA and by affecting the FMRP ability of cytoskeleton remodeling through Rho/Rac GTPases. To better define the relationship of FMRP with its interacting proteins during brain development, we have analyzed the expression pattern of FMRP and its interacting proteins in the cortex, striatum, hippocampus and cerebellum at different ages in wild type (WT) mice. FMRP and FXR2P were strongly expressed during the first week and gradually decreased thereafter, more rapidly in the cerebellum than in the cortex. FXR1P was also expressed early and showed a reduction at later stages of development with a similar developmental pattern in these two regions. CYFIP1 was expressed at all ages and peaked in the third post-natal week. In contrast, CYFIP2 and 82-FIP (only in forebrain regions) were moderately expressed at P3 and gradually increased after P7. In general, the expression pattern of each protein was similar in the regions examined, except for 82-FIP, which exhibited a strong expression at P3 and low levels at later developmental stages in the cerebellum. Our data indicate that FMRP and its interacting proteins have distinct developmental patterns of expression and suggest that FMRP may be preferentially associated to certain proteins in early and late developmental periods. In particular, the RNA-binding and cytoskeleton remodeling functions of FMRP may be differently modulated during development.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  82-FIP; CYFIP1; CYFIP2; FMRP; FXR1P; FXR2P

Mesh:

Substances:

Year:  2015        PMID: 25681562     DOI: 10.1016/j.ijdevneu.2015.02.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  27 in total

1.  Fragile X Mental Retardation Protein Requirements in Activity-Dependent Critical Period Neural Circuit Refinement.

Authors:  Caleb A Doll; Dominic J Vita; Kendal Broadie
Journal:  Curr Biol       Date:  2017-07-27       Impact factor: 10.834

2.  Longitudinal identification of clinically distinct neurophenotypes in young children with fragile X syndrome.

Authors:  Jennifer L Bruno; David Romano; Paul Mazaika; Amy A Lightbody; Heather Cody Hazlett; Joseph Piven; Allan L Reiss
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

3.  Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome.

Authors:  Keren K Griffiths; Aili Wang; Lifei Wang; Matthew Tracey; Giulio Kleiner; Catarina M Quinzii; Linlin Sun; Guang Yang; Jose F Perez-Zoghbi; Pawel Licznerski; Mu Yang; Elizabeth A Jonas; Richard J Levy
Journal:  FASEB J       Date:  2020-04-20       Impact factor: 5.191

4.  Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.

Authors:  L A Martinez; Maria Victoria Tejada-Simon
Journal:  Mol Neurobiol       Date:  2017-07-08       Impact factor: 5.590

5.  Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism.

Authors:  Rezvan Noroozi; Mir Davood Omrani; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2018-05-11       Impact factor: 3.584

6.  FMRP Mediates Chronic Ethanol-Induced Changes in NMDA, Kv4.2, and KChIP3 Expression in the Hippocampus.

Authors:  Kathryn B Spencer; Patrick J Mulholland; L Judson Chandler
Journal:  Alcohol Clin Exp Res       Date:  2016-05-05       Impact factor: 3.455

Review 7.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

8.  New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes.

Authors:  Sabiha Abekhoukh; H Bahar Sahin; Mauro Grossi; Samantha Zongaro; Thomas Maurin; Irene Madrigal; Daniele Kazue-Sugioka; Annick Raas-Rothschild; Mohamed Doulazmi; Pilar Carrera; Andrea Stachon; Steven Scherer; Maria Rita Drula Do Nascimento; Alain Trembleau; Ignacio Arroyo; Peter Szatmari; Isabel M Smith; Montserrat Milà; Adam C Smith; Angela Giangrande; Isabelle Caillé; Barbara Bardoni
Journal:  Dis Model Mech       Date:  2017-02-09       Impact factor: 5.758

9.  Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.

Authors:  Sachin Suresh Tiwari; Keiko Mizuno; Anshua Ghosh; Wajeeha Aziz; Claire Troakes; Jason Daoud; Vidushi Golash; Wendy Noble; Tibor Hortobágyi; Karl Peter Giese
Journal:  Brain       Date:  2016-08-14       Impact factor: 13.501

10.  Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.

Authors:  Zhou Xing; Minling Zeng; Huixian Hu; Hui Zhang; Zhuofang Hao; Yuesheng Long; Shengqiang Chen; Hang Su; Zhongmin Yuan; Meng Xu; Jingqi Chen
Journal:  Oncotarget       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.